Published in Infect Immun on August 01, 2004
The capsule of the fungal pathogen Cryptococcus neoformans. Adv Appl Microbiol (2009) 1.97
Cryptococcus neoformans in organ transplant recipients: impact of calcineurin-inhibitor agents on mortality. J Infect Dis (2007) 1.78
The relative susceptibility of mouse strains to pulmonary Cryptococcus neoformans infection is associated with pleiotropic differences in the immune response. Infect Immun (2007) 1.30
New concepts in antibody-mediated immunity. Infect Immun (2004) 1.19
IgM production by bone marrow plasmablasts contributes to long-term protection against intracellular bacterial infection. J Immunol (2010) 1.18
The absence of serum IgM enhances the susceptibility of mice to pulmonary challenge with Cryptococcus neoformans. J Immunol (2010) 1.15
Antibody-mediated protection against Cryptococcus neoformans pulmonary infection is dependent on B cells. Infect Immun (2005) 1.11
A peptide mimotope of type 8 pneumococcal capsular polysaccharide induces a protective immune response in mice. Infect Immun (2005) 1.07
TLR9 signaling is required for generation of the adaptive immune protection in Cryptococcus neoformans-infected lungs. Am J Pathol (2010) 1.06
Antibodies to Streptococcus pneumoniae capsular polysaccharide enhance pneumococcal quorum sensing. MBio (2011) 1.03
Antibody-mediated protection through cross-reactivity introduces a fungal heresy into immunological dogma. Infect Immun (2007) 1.00
The common Cryptococcus neoformans glucuronoxylomannan M2 motif elicits non-protective antibodies. Vaccine (2009) 1.00
X-linked immunodeficient mice exhibit enhanced susceptibility to Cryptococcus neoformans Infection. MBio (2013) 0.94
Therapeutic efficacy of a conjugate vaccine containing a peptide mimotope of cryptococcal capsular polysaccharide glucuronoxylomannan. Clin Vaccine Immunol (2008) 0.91
Molecular characterization of the early B cell response to pulmonary Cryptococcus neoformans infection. J Immunol (2012) 0.90
IL-23 dampens the allergic response to Cryptococcus neoformans through IL-17-independent and -dependent mechanisms. Am J Pathol (2012) 0.89
Cryptococcus neoformans-reactive and total immunoglobulin profiles of human immunodeficiency virus-infected and uninfected Ugandans. Clin Diagn Lab Immunol (2005) 0.88
Antibody response to Cryptococcus neoformans capsular polysaccharide glucuronoxylomannan in patients after solid-organ transplantation. Clin Vaccine Immunol (2006) 0.88
Host immunity to Cryptococcus neoformans. Future Microbiol (2015) 0.85
Characterization of a flocculation-like phenotype in Cryptococcus neoformans and its effects on pathogenesis. Cell Microbiol (2006) 0.83
Characterization of gene use and efficacy of mouse monoclonal antibodies to Streptococcus pneumoniae serotype 8. Clin Vaccine Immunol (2010) 0.83
Improved survival of mice deficient in secretory immunoglobulin M following systemic infection with Cryptococcus neoformans. Infect Immun (2009) 0.82
Diversity in the CDR3 region of V(H) is sufficient for most antibody specificities. Immunity (2000) 3.49
Protective murine monoclonal antibodies to Cryptococcus neoformans. Infect Immun (1992) 3.21
Antibodies elicited by a Cryptococcus neoformans-tetanus toxoid conjugate vaccine have the same specificity as those elicited in infection. J Infect Dis (1992) 2.98
Epidemiological evidence for dormant Cryptococcus neoformans infection. J Clin Microbiol (1999) 2.78
Characterization of a murine monoclonal antibody to Cryptococcus neoformans polysaccharide that is a candidate for human therapeutic studies. Antimicrob Agents Chemother (1998) 2.74
Serologic evidence for Cryptococcus neoformans infection in early childhood. Pediatrics (2001) 2.40
Facilitated isolation, purification, and analysis of glucuronoxylomannan of Cryptococcus neoformans. Infect Immun (1991) 2.19
A mAb recognizing a surface antigen of Mycobacterium tuberculosis enhances host survival. Proc Natl Acad Sci U S A (1998) 2.13
Protective and nonprotective monoclonal antibodies to Cryptococcus neoformans originating from one B cell. J Exp Med (1995) 2.11
Molecular characterization of the humoral responses to Cryptococcus neoformans infection and glucuronoxylomannan-tetanus toxoid conjugate immunization. J Exp Med (1993) 2.09
Antibody-mediated regulation of cellular immunity and the inflammatory response. Trends Immunol (2003) 2.00
Passive immunization against Cryptococcus neoformans with an isotype-switch family of monoclonal antibodies reactive with cryptococcal polysaccharide. Infect Immun (1990) 1.89
Induction of capsule growth in Cryptococcus neoformans by mammalian serum and CO(2). Infect Immun (2003) 1.89
More is not necessarily better: prozone-like effects in passive immunization with IgG. J Immunol (2003) 1.81
Monoclonal antibodies to surface antigens of Mycobacterium tuberculosis and their use in a modified enzyme-linked immunosorbent spot assay for detection of mycobacteria. J Clin Microbiol (1996) 1.76
Functional transplant of megabase human immunoglobulin loci recapitulates human antibody response in mice. Nat Genet (1997) 1.67
Direct measurement of antibody affinity distribution by hapten-inhibition enzyme immunoassay. Mol Immunol (1984) 1.61
Epitope location in the Cryptococcus neoformans capsule is a determinant of antibody efficacy. J Exp Med (1997) 1.60
Antibodies to a cell surface histone-like protein protect against Histoplasma capsulatum. J Clin Invest (2003) 1.60
Mouse-human immunoglobulin G1 chimeric antibodies with activities against Cryptococcus neoformans. Antimicrob Agents Chemother (1994) 1.48
Functional differences in idiotypically defined IgG1 anti-polysaccharide antibodies elicited by vaccination with Haemophilus influenzae type B polysaccharide-protein conjugates. J Immunol (1995) 1.47
The efficacy of complement-mediated phagocytosis of Cryptococcus neoformans is dependent on the location of C3 in the polysaccharide capsule and involves both direct and indirect C3-mediated interactions. Eur J Immunol (2003) 1.45
Antibodies to the Cryptococcus neoformans capsular glucuronoxylomannan are ubiquitous in serum from HIV+ and HIV- individuals. Clin Exp Immunol (1995) 1.45
Immunoglobulin M efficacy against Cryptococcus neoformans: mechanism, dose dependence, and prozone-like effects in passive protection experiments. J Immunol (2001) 1.42
Immunoglobulin VH clan and family identity predicts variable domain structure and may influence antigen binding. EMBO J (1992) 1.42
Germline antibody recognition of distinct carbohydrate epitopes. Nat Struct Biol (2003) 1.36
Molecular and idiotypic analysis of antibodies to Cryptococcus neoformans glucuronoxylomannan. Infect Immun (1994) 1.34
Isotype can affect the fine specificity of an antibody for a polysaccharide antigen. J Immunol (2002) 1.30
Antibody response to Cryptococcus neoformans proteins in rodents and humans. Infect Immun (1999) 1.26
Genetic control of the humoral response to cryptococcal capsular polysaccharide in mice. Immunogenetics (1988) 1.23
Analysis of human monoclonal antibodies elicited by vaccination with a Cryptococcus neoformans glucuronoxylomannan capsular polysaccharide vaccine. Infect Immun (1995) 1.21
Immunoglobulin light chain variable region gene sequences for human antibodies to Haemophilus influenzae type b capsular polysaccharide are dominated by a limited number of V kappa and V lambda segments and VJ combinations. J Clin Invest (1992) 1.21
Antibodies reactive with the cryptococcal capsular polysaccharide glucuronoxylomannan are present in sera from children with and without human immunodeficiency virus infection. J Infect Dis (1999) 1.17
Polysaccharides, mimotopes and vaccines for fungal and encapsulated pathogens. Trends Microbiol (2001) 1.17
A human IgM monoclonal antibody prolongs survival of mice with lethal cryptococcosis. J Infect Dis (1998) 1.15
Unmutated immunoglobulin M can protect mice from death by influenza virus infection. J Exp Med (2003) 1.15
Canonical structure repertoire of the antigen-binding site of immunoglobulins suggests strong geometrical restrictions associated to the mechanism of immune recognition. J Mol Biol (1995) 1.15
Molecular and functional characteristics of a protective human monoclonal antibody to serotype 8 Streptococcus pneumoniae capsular polysaccharide. Infect Immun (1999) 1.13
Oligoclonality of serum immunoglobulin G antibody responses to Streptococcus pneumoniae capsular polysaccharide serotypes 6B, 14, and 23F. Infect Immun (1997) 1.12
A cryptococcal capsular polysaccharide mimotope prolongs the survival of mice with Cryptococcus neoformans infection. J Immunol (2001) 1.10
Structure-function relationships for human antibodies to pneumococcal capsular polysaccharide from transgenic mice with human immunoglobulin Loci. Infect Immun (2002) 1.09
Variable efficacy of passive antibody administration against diverse Cryptococcus neoformans strains. Infect Immun (1995) 1.08
Human antibodies elicited by a pneumococcal vaccine express idiotypic determinants indicative of V(H)3 gene segment usage. J Infect Dis (1998) 1.04
Quantitative and qualitative differences in the serum antibody profiles of human immunodeficiency virus-infected persons with and without Cryptococcus neoformans meningitis. J Infect Dis (1999) 1.03
Modulation of polymorphonuclear cell interleukin-8 secretion by human monoclonal antibodies to type 8 pneumococcal capsular polysaccharide. Infect Immun (2003) 0.99
VH gene usage in humans: biased usage of the VH6 gene in immature B lymphoid cells. Eur J Immunol (1991) 0.98
Immune therapy for infectious diseases at the dawn of the 21st century: the past, present and future role of antibody therapy, therapeutic vaccination and biological response modifiers. Curr Pharm Des (2003) 0.97
Production of protective human antipneumococcal antibodies by transgenic mice with human immunoglobulin loci. Infect Immun (2000) 0.97
Immunogenicity and efficacy of Cryptococcus neoformans capsular polysaccharide glucuronoxylomannan peptide mimotope-protein conjugates in human immunoglobulin transgenic mice. Infect Immun (2004) 0.97
Molecular basis for immunoglobulin M specificity to epitopes in Cryptococcus neoformans polysaccharide that elicit protective and nonprotective antibodies. Infect Immun (2001) 0.93
Molecular characterization of human antibodies to bacterial antigens: utilization of the less frequently expressed VH2 and VH6 heavy chain variable region gene families. Mol Immunol (1993) 0.92
Peptide epitopes recognized by a human anti-cryptococcal glucuronoxylomannan antibody. Infect Immun (1997) 0.92
Variable region sequences of a protective human monoclonal antibody specific for the Haemophilus influenzae type b capsular polysaccharide. Infect Immun (1994) 0.92
Isolation of germinal centerlike events from human spleen RNA. Somatic hypermutation of a clonally related VH6DJH rearrangement expressed with IgM, IgG, and IgA. J Clin Invest (1993) 0.92
Effects of HIV infection on VH3 (D12 idiotope) B cells in vivo. J Acquir Immune Defic Syndr (1994) 0.91
Combinatorial immunoglobulin light chain variability creates sufficient B cell diversity to mount protective antibody responses against pathogen infections. Eur J Immunol (2003) 0.91
Selective usage of VH genes in adult human B lymphocyte repertoires. Scand J Immunol (1997) 0.91
Human splenic IgM immunoglobulin transcripts are mutated at high frequency. Mol Immunol (1994) 0.90
Use of the most JH-proximal human Ig H chain V region gene, VH6, in the expressed immune repertoire. J Immunol (1993) 0.90
The function of conserved amino acids in or near the complementarity determining regions for related antibodies to Cryptococcus neoformans glucuronoxylomannan. Mol Immunol (2003) 0.88
A pneumococcal capsular polysaccharide vaccine induces a repertoire shift with increased VH3 expression in peripheral B cells from human immunodeficiency virus (HIV)-uninfected but not HIV-infected persons. J Infect Dis (2000) 0.88
An anti-lipid A antibody obtained from the human fetal repertoire is encoded by VH6-V lambda 1 genes. Mol Immunol (1993) 0.86
Monoclonal antibodies reveal additional epitopes of serotype D Cryptococcus neoformans capsular glucuronoxylomannan that elicit protective antibodies. J Immunol (1998) 0.86
Aberrant and unstable expression of immunoglobulin genes in persons infected with human immunodeficiency virus. Blood (1998) 0.85
Antibody-antigen recognition: a canonical structure paradigm. J Mol Evol (1996) 0.84
The damage-response framework of microbial pathogenesis. Nat Rev Microbiol (2003) 4.07
Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls. Neuron (2013) 3.27
Passive antibody therapy for infectious diseases. Nat Rev Microbiol (2004) 2.64
Antibody-mediated regulation of cellular immunity and the inflammatory response. Trends Immunol (2003) 2.00
Prevalence of the metabolic syndrome and its relation to cardiovascular disease in an elderly Chinese population. J Am Coll Cardiol (2006) 1.98
Uterine massage to reduce blood loss after vaginal delivery: a randomized controlled trial. Obstet Gynecol (2013) 1.96
Transcriptional and functional analyses of SLC12A3 mutations: new clues for the pathogenesis of Gitelman syndrome. J Am Soc Nephrol (2007) 1.84
Inhibition of HIV-1 replication by GB virus C infection through increases in RANTES, MIP-1alpha, MIP-1beta, and SDF-1. Lancet (2004) 1.78
The human airway epithelial basal cell transcriptome. PLoS One (2011) 1.69
Glycosylation site-specific analysis of clade C HIV-1 envelope proteins. J Proteome Res (2009) 1.61
Epigenetic regulation of motor neuron cell death through DNA methylation. J Neurosci (2011) 1.61
Preferential use of the VH5-51 gene segment by the human immune response to code for antibodies against the V3 domain of HIV-1. Mol Immunol (2008) 1.60
The mitochondrial permeability transition pore in motor neurons: involvement in the pathobiology of ALS mice. Exp Neurol (2009) 1.50
Tourniquet device for hemorrhage control during cesarean section of complete placenta previa pregnancies. J Obstet Gynaecol Res (2013) 1.48
Restoration of connexin26 protein level in the cochlea completely rescues hearing in a mouse model of human connexin30-linked deafness. Proc Natl Acad Sci U S A (2007) 1.44
Atoh1 directs the formation of sensory mosaics and induces cell proliferation in the postnatal mammalian cochlea in vivo. J Neurosci (2012) 1.43
A reappraisal of humoral immunity based on mechanisms of antibody-mediated protection against intracellular pathogens. Adv Immunol (2006) 1.42
Single-cell imaging of retinal ganglion cell apoptosis with a cell-penetrating, activatable peptide probe in an in vivo glaucoma model. Proc Natl Acad Sci U S A (2009) 1.40
Accidental virulence, cryptic pathogenesis, martians, lost hosts, and the pathogenicity of environmental microbes. Eukaryot Cell (2007) 1.38
Influence of neutropenia on the course of serotype 8 pneumococcal pneumonia in mice. Infect Immun (2007) 1.36
A novel mechanism for connexin 26 mutation linked deafness: cell death caused by leaky gap junction hemichannels. Laryngoscope (2006) 1.36
An improved cell-penetrating, caspase-activatable, near-infrared fluorescent peptide for apoptosis imaging. Bioconjug Chem (2009) 1.34
Targeted connexin26 ablation arrests postnatal development of the organ of Corti. Biochem Biophys Res Commun (2009) 1.32
Impaired endothelial function in the brachial artery after Kawasaki disease and the effects of intravenous administration of vitamin C. Pediatr Infect Dis J (2003) 1.26
Connexin30 null and conditional connexin26 null mice display distinct pattern and time course of cellular degeneration in the cochlea. J Comp Neurol (2009) 1.25
Direct interaction with Rab11a targets the epithelial Ca2+ channels TRPV5 and TRPV6 to the plasma membrane. Mol Cell Biol (2006) 1.25
Gitelman's syndrome: towards genotype-phenotype correlations? Pediatr Nephrol (2006) 1.24
An 85-aa segment of the GB virus type C NS5A phosphoprotein inhibits HIV-1 replication in CD4+ Jurkat T cells. Proc Natl Acad Sci U S A (2006) 1.23
Tissue involution and the acute phase response. Ann N Y Acad Sci (2003) 1.21
Diverse deafness mechanisms of connexin mutations revealed by studies using in vitro approaches and mouse models. Brain Res (2009) 1.20
Evaluation by high-resolution ultrasonography of endothelial function in brachial artery after Kawasaki disease and the effects of intravenous administration of vitamin C. Circ J (2002) 1.20
New concepts in antibody-mediated immunity. Infect Immun (2004) 1.19
CD8+ cells enhance resistance to pulmonary serotype 3 Streptococcus pneumoniae infection in mice. J Immunol (2010) 1.17
EGF shifts human airway basal cell fate toward a smoking-associated airway epithelial phenotype. Proc Natl Acad Sci U S A (2013) 1.16
The absence of serum IgM enhances the susceptibility of mice to pulmonary challenge with Cryptococcus neoformans. J Immunol (2010) 1.15
Towards a vaccine for Cryptococcus neoformans: principles and caveats. FEMS Yeast Res (2006) 1.15
TBLR1 regulates the expression of nuclear hormone receptor co-repressors. BMC Cell Biol (2006) 1.14
Hyperbaric oxygen attenuates apoptosis and decreases inflammation in an ischemic wound model. J Invest Dermatol (2008) 1.14
Amnesia produced by altered release of neurotransmitters after intraamygdala injections of a protein synthesis inhibitor. Proc Natl Acad Sci U S A (2007) 1.13
GB virus type C/hepatitis G virus: a non-pathogenic flavivirus associated with prolonged survival in HIV-infected individuals. Microbes Infect (2003) 1.12
Viruses within the Flaviviridae decrease CD4 expression and inhibit HIV replication in human CD4+ cells. J Immunol (2009) 1.10
Digenic inheritance of non-syndromic deafness caused by mutations at the gap junction proteins Cx26 and Cx31. Hum Genet (2008) 1.08
Diencephalic damage decreases hippocampal acetylcholine release during spontaneous alternation testing. Learn Mem (2003) 1.06
Real-time polymerase chain reaction microRNA detection based on enzymatic stem-loop probes ligation. Anal Chem (2009) 1.06
Tissue kallikrein stimulates Ca(2+) reabsorption via PKC-dependent plasma membrane accumulation of TRPV5. EMBO J (2006) 1.05
The beta-glucuronidase klotho exclusively activates the epithelial Ca2+ channels TRPV5 and TRPV6. Nephrol Dial Transplant (2008) 1.05
Fc gamma receptor 3A polymorphism and risk for HIV-associated cryptococcal disease. MBio (2013) 1.04
BMI versus the metabolic syndrome in relation to cardiovascular risk in elderly Chinese individuals. Diabetes Care (2007) 1.03
Stat3 mediates expression of autotaxin in breast cancer. PLoS One (2011) 1.03
Antibodies to Streptococcus pneumoniae capsular polysaccharide enhance pneumococcal quorum sensing. MBio (2011) 1.03
Downregulation of electroacupuncture at ST36 on TNF-alpha in rats with ulcerative colitis. World J Gastroenterol (2003) 1.02
Vertical alveolar ridge augmentation with beta-tricalcium phosphate and autologous osteoblasts in canine mandible. Biomaterials (2009) 1.01
Pyrethroid susceptibility of malaria vectors in four Districts of western Kenya. Parasit Vectors (2014) 1.00
Antibody-mediated protection through cross-reactivity introduces a fungal heresy into immunological dogma. Infect Immun (2007) 1.00
Expression of TREM-1 mRNA in acute pancreatitis. World J Gastroenterol (2004) 0.99
GB virus type C envelope protein E2 elicits antibodies that react with a cellular antigen on HIV-1 particles and neutralize diverse HIV-1 isolates. J Immunol (2010) 0.99
Modulation of polymorphonuclear cell interleukin-8 secretion by human monoclonal antibodies to type 8 pneumococcal capsular polysaccharide. Infect Immun (2003) 0.99
Qualitative change in antibody responses of human immunodeficiency virus-infected individuals to pneumococcal capsular polysaccharide vaccination associated with highly active antiretroviral therapy. J Infect Dis (2003) 0.99
Connexin29 is highly expressed in cochlear Schwann cells, and it is required for the normal development and function of the auditory nerve of mice. J Neurosci (2006) 0.99
Induced humoral immunity and vaccination against major human fungal pathogens. Curr Opin Microbiol (2002) 0.98
Current concepts in host-microbe interaction leading to pneumococcal pneumonia. Curr Opin Infect Dis (2013) 0.98
The outcome of Cryptococcus neoformans intracellular pathogenesis in human monocytes. BMC Microbiol (2009) 0.98
Identification and characterization of a human monoclonal antagonistic antibody AL-57 that preferentially binds the high-affinity form of lymphocyte function-associated antigen-1. J Leukoc Biol (2006) 0.98
A human monoclonal immunoglobulin M reduces bacteremia and inflammation in a mouse model of systemic pneumococcal infection. Clin Vaccine Immunol (2007) 0.97
Immunogenicity and efficacy of Cryptococcus neoformans capsular polysaccharide glucuronoxylomannan peptide mimotope-protein conjugates in human immunoglobulin transgenic mice. Infect Immun (2004) 0.97
Pneumococcal capsular polysaccharide vaccine-mediated protection against serotype 3 Streptococcus pneumoniae in immunodeficient mice. Infect Immun (2007) 0.96
Molecular pathology in the lungs of severe acute respiratory syndrome patients. Am J Pathol (2007) 0.96
Inhibitory synaptic regulation of motoneurons: a new target of disease mechanisms in amyotrophic lateral sclerosis. Mol Neurobiol (2011) 0.96
Exchange protein directly activated by cAMP plays a critical role in bacterial invasion during fatal rickettsioses. Proc Natl Acad Sci U S A (2013) 0.95
Neferine, a bisbenzylisoquinline alkaloid attenuates bleomycin-induced pulmonary fibrosis. Eur J Pharmacol (2009) 0.95
Acetylcholine release in hippocampus and striatum during testing on a rewarded spontaneous alternation task. Neurobiol Learn Mem (2005) 0.95
Quantitative analysis of zeptomole microRNAs based on isothermal ramification amplification. RNA (2009) 0.95
Early postnatal virus inoculation into the scala media achieved extensive expression of exogenous green fluorescent protein in the inner ear and preserved auditory brainstem response thresholds. J Gene Med (2013) 0.95
X-linked immunodeficient mice exhibit enhanced susceptibility to Cryptococcus neoformans Infection. MBio (2013) 0.94
Acetylcholine release in the hippocampus and striatum during place and response training. Learn Mem (2005) 0.94
Detection of urinary excreted fungal galactomannan-like antigens for diagnosis of invasive aspergillosis. PLoS One (2012) 0.94
VAV2 and VAV3 as candidate disease genes for spontaneous glaucoma in mice and humans. PLoS One (2010) 0.93
Characterization of a peptide domain within the GB virus C NS5A phosphoprotein that inhibits HIV replication. PLoS One (2008) 0.93
A human monoclonal antibody against insulin-like growth factor-II blocks the growth of human hepatocellular carcinoma cell lines in vitro and in vivo. Mol Cancer Ther (2010) 0.93
Chronic traumatic pseudoaneurysm of the ascending aorta causing right ventricular inflow obstruction. Circ J (2003) 0.92
Identification of a novel homozygous deletion region at 6q23.1 in medulloblastomas using high-resolution array comparative genomic hybridization analysis. Clin Cancer Res (2005) 0.92
Paracrine role for mesenchymal stem cells in acute myocardial infarction. Biol Pharm Bull (2009) 0.92
Microbial virulence results from the interaction between host and microorganism. Trends Microbiol (2003) 0.92
Overlapping and distinct roles for PI3Kbeta and gamma isoforms in S1P-induced migration of human and mouse endothelial cells. Cardiovasc Res (2008) 0.91
Epigenetic inactivation of DLC-1 in supratentorial primitive neuroectodermal tumor. Hum Pathol (2005) 0.91
Therapeutic efficacy of a conjugate vaccine containing a peptide mimotope of cryptococcal capsular polysaccharide glucuronoxylomannan. Clin Vaccine Immunol (2008) 0.91
Commentary: IDSA guidelines for improving the teaching of preclinical medical microbiology and infectious diseases. Acad Med (2010) 0.90
Characterization of a peptide domain within the GB virus C envelope glycoprotein (E2) that inhibits HIV replication. Virology (2012) 0.90
IgG gene expression and its possible significance in prostate cancers. Prostate (2011) 0.90
The weapon potential of a microbe. Trends Microbiol (2004) 0.90
Different functional consequences of two missense mutations in the GJB2 gene associated with non-syndromic hearing loss. Hum Mutat (2009) 0.90
Serotype distribution of Cryptococcus neoformans in patients in a tertiary care center in India. Med Mycol (2004) 0.90
What is a pathogen? Ann Med (2002) 0.90
Molecular characterization of the early B cell response to pulmonary Cryptococcus neoformans infection. J Immunol (2012) 0.90
Melatonin-mediated cytoprotection against hyperglycemic injury in Müller cells. PLoS One (2012) 0.90
Potential inhibition of cytochrome P450 3A4 by propofol in human primary hepatocytes. World J Gastroenterol (2003) 0.89
Cystic fibrosis transmembrane conductance regulator regulates epithelial cell response to Aspergillus and resultant pulmonary inflammation. Am J Respir Crit Care Med (2011) 0.89
Establishment of a knock-in mouse model with the SLC26A4 c.919-2A>G mutation and characterization of its pathology. PLoS One (2011) 0.89
Characterization of an immunodominant antigenic site on GB virus C glycoprotein E2 that is involved in cell binding. J Virol (2006) 0.89